Michael Dörks1, Guido Schmiemann2, Falk Hoffmann3. 1. Department of Health Services Research, Carl von Ossietzky University Oldenburg, Ammerländer Heerstrasse 140, 26111, Oldenburg, Germany. michael.doerks@uni-oldenburg.de. 2. Institute for Public Health and Nursing Science, Department for Health Services Research, University of Bremen, Bremen, Germany. 3. Department of Health Services Research, Carl von Ossietzky University Oldenburg, Ammerländer Heerstrasse 140, 26111, Oldenburg, Germany.
Abstract
PURPOSE: Injudicious pro re nata (PRN) or as needed prescribing can lead to polypharmacy, potentially harmful drug interactions and total drug doses exceeding the maximum recommended. Despite the known risks and the widespread administration, there is a paucity of current research examining the use of PRN drugs in nursing homes. Therefore, we examined characteristics of PRN drug use and potential predictors in nursing homes. METHODS: The multicentre cross-sectional study included a heterogeneous sample of 21 nursing homes in Northwestern Germany comprising 852 residents. Descriptive statistics and multivariable regression models were used to analyse and present the collected data. RESULTS: Nearly three quarters (74.9 %) of all residents were treated with at least one PRN medication. On average, each resident was prescribed 2.5 ± 2.3 PRN drugs. On average, residents with no PRN prescriptions stayed since 2.4 ± 2.9 years in the nursing home. Residents with five and more PRN prescriptions were on average since 4.8 ± 4.3 years in the nursing home. In a multivariable analysis, length of stay above the median of 2.1 years (OR 2.4; 95 % CI 1.8, 3.2) and polypharmacy with five or more long-term drugs (OR 2.1; 95 % CI 1.5, 2.9) were associated with a higher number of PRN prescriptions. Most commonly used PRN drug was acetaminophen, which was prescribed to 289 (33.9 %) residents. CONCLUSIONS: The high prevalence of PRN medication should be taken into account when considering polypharmacy and inappropriate drug prescribing or using screening tools like the STOPP/START (screening tool of older persons' potentially inappropriate prescriptions/screening tool to alert doctors to right) criteria in nursing homes. Physicians should regularly reconsider the need of each PRN drug on the medication schedule. Moreover, the high prevalence of PRN medication and the association with length of stay highlights the importance of an accurate documentation.
PURPOSE: Injudicious pro re nata (PRN) or as needed prescribing can lead to polypharmacy, potentially harmful drug interactions and total drug doses exceeding the maximum recommended. Despite the known risks and the widespread administration, there is a paucity of current research examining the use of PRN drugs in nursing homes. Therefore, we examined characteristics of PRN drug use and potential predictors in nursing homes. METHODS: The multicentre cross-sectional study included a heterogeneous sample of 21 nursing homes in Northwestern Germany comprising 852 residents. Descriptive statistics and multivariable regression models were used to analyse and present the collected data. RESULTS: Nearly three quarters (74.9 %) of all residents were treated with at least one PRN medication. On average, each resident was prescribed 2.5 ± 2.3 PRN drugs. On average, residents with no PRN prescriptions stayed since 2.4 ± 2.9 years in the nursing home. Residents with five and more PRN prescriptions were on average since 4.8 ± 4.3 years in the nursing home. In a multivariable analysis, length of stay above the median of 2.1 years (OR 2.4; 95 % CI 1.8, 3.2) and polypharmacy with five or more long-term drugs (OR 2.1; 95 % CI 1.5, 2.9) were associated with a higher number of PRN prescriptions. Most commonly used PRN drug was acetaminophen, which was prescribed to 289 (33.9 %) residents. CONCLUSIONS: The high prevalence of PRN medication should be taken into account when considering polypharmacy and inappropriate drug prescribing or using screening tools like the STOPP/START (screening tool of older persons' potentially inappropriate prescriptions/screening tool to alert doctors to right) criteria in nursing homes. Physicians should regularly reconsider the need of each PRN drug on the medication schedule. Moreover, the high prevalence of PRN medication and the association with length of stay highlights the importance of an accurate documentation.
Entities:
Keywords:
Nursing home; Older people; Polypharmacy; Pro re nata (as needed) drug use
Authors: Falk Hoffmann; Hanna Kaduszkiewicz; Gerd Glaeske; Hendrik van den Bussche; Daniela Koller Journal: Aging Clin Exp Res Date: 2014-03-20 Impact factor: 3.636
Authors: Janine A Cooper; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Marie C Bradley; Cristín Ryan; Carmel M Hughes Journal: BMJ Open Date: 2015-12-09 Impact factor: 2.692
Authors: Paula Carder; Sheryl Zimmerman; Christopher J Wretman; John S Preisser; Sarah Dys; Philip D Sloane Journal: J Am Med Dir Assoc Date: 2021-12-14 Impact factor: 7.802
Authors: Esa Yh Chen; J Simon Bell; Jenni Ilomaki; Claire Keen; Megan Corlis; Michelle Hogan; Jan Van Emden; Sarah N Hilmer; Janet K Sluggett Journal: Clin Interv Aging Date: 2019-10-22 Impact factor: 4.458
Authors: Diana Velasquez Reyes; Hema Patel; Nicola Lautenschlager; Andrew H Ford; Eleanor Curran; Rachael Kelly; Rhoda Lai; Terence Chong; Leon Flicker; David Ekers; Simon Gilbody; Christopher Etherton-Beer; Dina Lo Giudice; Kathryn A Ellis; Angelita Martini; Osvaldo P Almeida Journal: BMJ Open Date: 2019-10-31 Impact factor: 2.692